Cargando…
An Integrated Approach for Assessing the Impact of Renal Impairment on Pharmacokinetics of Drugs in Development: Pivotal Role of PBPK Modelling
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596427/ https://www.ncbi.nlm.nih.gov/pubmed/33934342 http://dx.doi.org/10.1002/cpt.2243 |
_version_ | 1784600376816697344 |
---|---|
author | Rowland Yeo, Karen Gil Berglund, Eva |
author_facet | Rowland Yeo, Karen Gil Berglund, Eva |
author_sort | Rowland Yeo, Karen |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8596427 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85964272021-12-02 An Integrated Approach for Assessing the Impact of Renal Impairment on Pharmacokinetics of Drugs in Development: Pivotal Role of PBPK Modelling Rowland Yeo, Karen Gil Berglund, Eva Clin Pharmacol Ther Perspectives John Wiley and Sons Inc. 2021-05-02 2021-11 /pmc/articles/PMC8596427/ /pubmed/33934342 http://dx.doi.org/10.1002/cpt.2243 Text en © 2021 The Authors. Clinical Pharmacology & Therapeutics published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Perspectives Rowland Yeo, Karen Gil Berglund, Eva An Integrated Approach for Assessing the Impact of Renal Impairment on Pharmacokinetics of Drugs in Development: Pivotal Role of PBPK Modelling |
title | An Integrated Approach for Assessing the Impact of Renal Impairment on Pharmacokinetics of Drugs in Development: Pivotal Role of PBPK Modelling |
title_full | An Integrated Approach for Assessing the Impact of Renal Impairment on Pharmacokinetics of Drugs in Development: Pivotal Role of PBPK Modelling |
title_fullStr | An Integrated Approach for Assessing the Impact of Renal Impairment on Pharmacokinetics of Drugs in Development: Pivotal Role of PBPK Modelling |
title_full_unstemmed | An Integrated Approach for Assessing the Impact of Renal Impairment on Pharmacokinetics of Drugs in Development: Pivotal Role of PBPK Modelling |
title_short | An Integrated Approach for Assessing the Impact of Renal Impairment on Pharmacokinetics of Drugs in Development: Pivotal Role of PBPK Modelling |
title_sort | integrated approach for assessing the impact of renal impairment on pharmacokinetics of drugs in development: pivotal role of pbpk modelling |
topic | Perspectives |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596427/ https://www.ncbi.nlm.nih.gov/pubmed/33934342 http://dx.doi.org/10.1002/cpt.2243 |
work_keys_str_mv | AT rowlandyeokaren anintegratedapproachforassessingtheimpactofrenalimpairmentonpharmacokineticsofdrugsindevelopmentpivotalroleofpbpkmodelling AT gilberglundeva anintegratedapproachforassessingtheimpactofrenalimpairmentonpharmacokineticsofdrugsindevelopmentpivotalroleofpbpkmodelling AT rowlandyeokaren integratedapproachforassessingtheimpactofrenalimpairmentonpharmacokineticsofdrugsindevelopmentpivotalroleofpbpkmodelling AT gilberglundeva integratedapproachforassessingtheimpactofrenalimpairmentonpharmacokineticsofdrugsindevelopmentpivotalroleofpbpkmodelling |